Visit of the Kemerovo Oblast – Kuzbass Governor to the “Avexima Siberia” LLC, Pharmaceutical Plant

Visit of the Kemerovo Oblast – Kuzbass Governor to the “Avexima Siberia” LLC, Pharmaceutical Plant


The Kemerovo Oblast – Kuzbass Governor, Sergey Tsivilev, visited the “Avexima Siberia” LLC, Chemical and Pharmaceutical Plant in Anzhero-Sudzhensk town.

During the visit, the regional leader held a working meeting on issues related to supporting the Kuzbass manufacturer (import substitution) with the participation of the heads of the regional departments. The meeting noted the high production potential of the “Avexima Siberia” enterprise and outlined steps to expand the range of the plant's products, which will fully meet the region's needs for modern and high-quality medicines for the next few years.


According to the Governor, given the current situation in the world, the demand for high-quality domestically produced drugs is particularly high today, and at the same time, the region has all the opportunities to support local Russian manufacturers. Therefore, work in this direction will be scaled up in the near future.

Following the meeting, a Working Group was formed under the leadership of Deputy Chairman of the Government of the Kemerovo Oblast – Kuzbass - Minister of Industry and Trade, Leonid Vladimirovich Starosvet. The group includes the heads of the Ministry of Economic Development and the Ministry of Health of the Oblast, the Avexima Company CEO, Elena Tkachenko, the CEO of the “Avexima Siberia” Plant, Lyudmila Solodukhina, as well as the Head of the Anzhero-Sudzhensky Urban Okrug, Aleksandr Rybalko.



For reference:

“Avexima Siberia”, LLC is one of the few Russian enterprises that has preserved and uses production facilities for synthesizing substances, as well as a laboratory complex equipped with modern analytical equipment. At present, this is a rare resource that provides a clear competitive advantage, since it allows for the strategy of bringing innovative medicines to the market.

Since 2012, the enterprise has been a production unit of the Avexima Company.

The enterprise produces more than 100 types of finished dosage forms, as well as 6 active pharmaceutical substances for in-house production of medicinal products and for sale. The tableted medicines production is dominant. The product range includes medicines from the “Vital and Essential Drugs List”. The company has licenses for the production of tablets, coated tablets, hard gelatin capsules, infusion solutions, powders in sachets and polymer jars, injection solutions in vials, suppositories, gels, ointments, and creams.

The enterprise development plans include the construction of additional production buildings to localize analogs of imported medicinal products to achieve the country's drug sovereignty in the current situation context with the drug supplies possible restrictions from unfriendly countries. The enterprise area will allow for additional production facilities placing to increase the manufactured products volumes required in the framework of import substitution not only within the Kuzbass territory, but throughout the Russian Federation.

Other news


Nobazit® - new indications for use

On March 28, 2023, within the framework of the XV Annual All-Russian Congress on Infectious Diseases named after the Academician V.I. Pokrovsky, a symposium was held on the viral diseases treatment current issues, entitled “Universal Approaches to the Therapy of Respiratory Viral Infections during the COVID-19 Pandemic.”


Antiviral drug “Nobazit” from “Avexima”, the Russian pharmaceutical company, at the main musical event of the year – the National Music Award “Golden Gramophone”.

The modern antiviral drug “Nobazit” has become the official sponsor of the National Music Award “Golden Gramophone”, which took place on December 10, 2022. As a gift from the sponsor, the singer and composer Dmitry Malikov received a supply of the antiviral drug “Nobazit”.


FURACILIN AVEXIMA New Packaging Release

The “Avexima”, OJSC, Pharmaceutical Company, informs you about the release of FURACILIN AVEKSIMA effervescent tablets No. 20 (5 strips of 4 tablets each) on the market in October 2022.